Exploring the Impact of Group-Administered Psilocybin on Psychological Flexibility
Psychedelic-assisted therapy (PAT) is gaining momentum as a promising approach for treating various mental health conditions. Recent research has focused not only on symptom reduction but also on understanding the underlying psychological processes that drive change during such therapies. A team of researchers from Portland Institute for Psychedelic Science, including Jason Luoma PhD, Brian Pilecki PhD, and Kati Lear PhD, has recently contributed to this growing body of knowledge by conducting a pilot study on the effects of group-administered psilocybin on psychological flexibility.
Understanding Psychological Flexibility
Psychological flexibility is a concept at the core of Acceptance and Commitment Therapy (ACT) and is increasingly recognized as a crucial process in mental health. It refers to the ability to stay in the present moment, adapt to changing circumstances, and act in ways that align with one's values, even in the face of difficult emotions or thoughts. In the context of psychedelic therapy, enhancing psychological flexibility may help individuals better integrate their experiences, leading to more meaningful and lasting therapeutic outcomes.
The Study: Setting and Methodology
This pilot study took place in a psilocybin retreat in Jamaica, where the substance is legal. Nine participants, aged 41 to 68, attended a seven-day retreat, during which they participated in three psilocybin sessions. The participants completed a series of psychological assessments before the retreat, two weeks after, and six months later. These assessments included measures of psychological flexibility, such as the Acceptance and Action Questionnaire (AAQ-II), Cognitive Fusion Questionnaire (CFQ), and the Valuing Questionnaire (VQ).
The retreat environment was designed to foster a sense of community and support, with group-based preparation and integration sessions led by the retreat staff. Participants also shared living quarters and meals, which further promoted a cohesive group experience. The psilocybin doses varied between 5 and 12 grams of dried mushrooms, allowing each participant to choose their preferred dose.
Key Findings: Enhancing Psychological Flexibility
The results of the study are encouraging and suggest that group-administered psilocybin can significantly enhance various facets of psychological flexibility. Participants demonstrated large improvements in cognitive defusion, which refers to the ability to distance oneself from unhelpful thoughts, and valued living, which involves engaging in behaviors that are consistent with one's values. These changes were observed both at the two-week and six-month follow-up points, indicating that the benefits of the psilocybin experience were not only immediate but also enduring.
Additionally, participants reported increases in self-compassion, a construct related to psychological flexibility, and social safeness, which reflects a sense of comfort and safety in social situations. These findings suggest that psilocybin may help individuals develop a kinder and more accepting relationship with themselves and others, which could contribute to better mental health outcomes.
Interestingly, while the study found significant improvements in these specific areas, changes in general psychological flexibility as measured by the AAQ-II were more modest. This highlights the importance of using more targeted measures to capture the nuanced effects of psychedelic experiences on psychological processes.
Implications for Psychedelic-Assisted Therapy
The findings of this pilot study underscore the potential of psilocybin to enhance psychological flexibility, a key process in mental health. By improving individuals' ability to adapt to their circumstances and act in accordance with their values, psilocybin-assisted therapy may offer lasting benefits beyond symptom reduction. Moreover, the study highlights the importance of integrating therapeutic approaches like ACT into psychedelic-assisted therapy.
Conclusion
As research on psychedelic-assisted therapy continues to grow, studies like this one conducted by Portland Psychotherapy provide valuable insights into the psychological processes that drive change. By focusing on psychological flexibility, researchers can better understand how to optimize psychedelic experiences for therapeutic benefit, paving the way for more effective and accessible mental health treatments in the future. Techniques like Acceptance and Commitment Therapy that promote cognitive defusion, values clarification, and self-compassion could be particularly valuable during the preparation and integration phases of psilocybin therapy If you are interested in learning more about the potential benefits of psilocybin and other psychedelics in therapy, you can explore the ongoing research and clinical trials being conducted at Portland Institute for Psychedelic Science. The work of Dr. Jason Luoma, Dr. Brian Pilecki, and Dr. Kati Lear is contributing to a deeper understanding of how these substances can be used to promote psychological well-being.